Cardiol Res

Cardiology Research, ISSN 1923-2829 print, 1923-2837 online, Open Access

Article copyright, the authors; Journal compilation copyright, Cardiol Res and Elmer Press Inc

Journal website https://www.cardiologyres.org

Original Article

Volume 2, Number 5, October 2011, pages 229-235

Short-Term Left Ventricular Remodeling After Revascularization in Subacute Total and Subtotal Occlusion With the Infarct-Related Left Anterior Descending Artery

Figure 1. Percentage changes of echocardiographic parameters in three groups. P < 0.05 was accepted as a statistically significant. LV:Left ventricular LVDD: Left ventricular diastolic diameter, LVSD: Left ventricular systolic diameter, LVEDV: Left ventricular enddiastolic volume, LVESV: Left ventricular endsystolic volume, LVEF: Left ventricular ejection fraction.

**Table 1.** Baseline Characteristics of All Patients in Three Groups
	Total-PCI Group (n:18)	Total-Medical Group (n:19)	Subtotal-PCI Group (n:20)	P value
Data expressed as mean ± SD, P < 0.05 was accepted as a statistically significant. DM: diabetes mellitus, HT: hypertension, CVD: cerebrovascular disease, LDL-C: low density lipoprotein, HDL-C: high density lipoprotein, T.CHOL: total cholesterol, TG: triglyceride
Age	62 ± 12	65 ± 8	59 ± 12	0.2
Female (n,%)	5 (27)	6 (31)	6 (30)	0.9
DM (n,%)	8 (44)	9 (47)	4 (20)	0.1
HT (n,%)	9 (50)	10 (52)	6 (30)	0.3
Smoke (n,%)	11 (61)	10 (52)	12 (60)	0.8
CVD (n,%)	1 (5)	2 (10)	0	0.3
NYHA Class (n,%)
I	7 (39)	8 (42)	9 (45)	0.9
II	11(61)	11(58)	11(55)	0.9
III- IV	0	0	0
Blood Pressure (mmHg)
Diastolic	82 ± 18	85 ± 15	75 11	0.1
Systolic	133 ± 23	137 ± 28	125 ± 22	0.3
Creatinine (mg/dl)	1.0 ± 0.2	1.1 ± 0.4	0.9 ± 0.1	0.1
Lipid profile (mg/dl)
LDL-C	120 ± 29	116 ± 43	118 ± 34	0.9
HDL-C	39 ± 9	41 ± 10	37 ± 8	0.4
T.CHOL	192 ± 46	183 ± 54	184 ± 42	0.8
TG	165 ± 131	129 ± 89	144 ± 80	0.5

Table 1. Baseline Characteristics of All Patients in Three Groups

Total-PCI Group (n:18)

Total-Medical Group (n:19)

Subtotal-PCI Group (n:20)

P value

Data expressed as mean ± SD, P < 0.05 was accepted as a statistically significant. DM: diabetes mellitus, HT: hypertension, CVD: cerebrovascular disease, LDL-C: low density lipoprotein, HDL-C: high density lipoprotein, T.CHOL: total cholesterol, TG: triglyceride

Age

62 ± 12

65 ± 8

59 ± 12

0.2

Female (n,%)

5 (27)

6 (31)

6 (30)

0.9

DM (n,%)

8 (44)

9 (47)

4 (20)

0.1

HT (n,%)

9 (50)

10 (52)

6 (30)

0.3

Smoke (n,%)

11 (61)

10 (52)

12 (60)

0.8

CVD (n,%)

1 (5)

2 (10)

0.3

NYHA Class (n,%)

7 (39)

8 (42)

9 (45)

0.9

11(61)

11(58)

11(55)

0.9

III- IV

Blood Pressure (mmHg)

Diastolic

82 ± 18

85 ± 15

75 11

0.1

Systolic

133 ± 23

137 ± 28

125 ± 22

0.3

Creatinine (mg/dl)

1.0 ± 0.2

1.1 ± 0.4

0.9 ± 0.1

0.1

Lipid profile (mg/dl)

LDL-C

120 ± 29

116 ± 43

118 ± 34

0.9

HDL-C

39 ± 9

41 ± 10

37 ± 8

0.4

T.CHOL

192 ± 46

183 ± 54

184 ± 42

0.8

165 ± 131

129 ± 89

144 ± 80

0.5

**Table 2.** The Change of Echocardiographic Parameters at Baseline and First Month in the Total-PCI Group
	Baseline	First month	p value
Data expressed as mean ± SD, P < 0.05 was accepted as a statistically significant. LV: Left ventricular LVDD: Left ventricular diastolic diameter, LVSD: Left ventricular systolic diameter, LVEDV: Left ventricular enddiastolic volume, LVESV: Left ventricular endsystolic volume, LVEF: Left ventricular ejection fraction, LVM: Left ventricular mass, LAD: left atrial diameter, sPAP: systolic pulmonary artery pressure, E/E’: ratio of transmitral E velosity to myocardial E velosity
LVSD (cm)	3.4 ± 0.4	3.5 ± 0.4	0.1
LVDD (cm)	4.8 ± 0.4	4.9 ± 0.3	0.02
LVESV (mL)	59 ± 27	68 ± 26	0.03
LVEDV (mL)	98 ± 35	114 ± 35	0.01
LVEF (%)	39 ± 8	40 ± 8	0.1
LV Mass (gr)	198 ± 57	218 ± 54	0.005
LAD (cm)	3.6 ± 0.3	3.7 ± 0.2	0.03
sPAP (mmHg)	33 ± 12	34 ± 12	0.5
E/E’	11±5	8±4	0.05

Table 2. The Change of Echocardiographic Parameters at Baseline and First Month in the Total-PCI Group

Baseline

First month

p value

Data expressed as mean ± SD, P < 0.05 was accepted as a statistically significant. LV: Left ventricular LVDD: Left ventricular diastolic diameter, LVSD: Left ventricular systolic diameter, LVEDV: Left ventricular enddiastolic volume, LVESV: Left ventricular endsystolic volume, LVEF: Left ventricular ejection fraction, LVM: Left ventricular mass, LAD: left atrial diameter, sPAP: systolic pulmonary artery pressure, E/E’: ratio of transmitral E velosity to myocardial E velosity

LVSD (cm)

3.4 ± 0.4

3.5 ± 0.4

0.1

LVDD (cm)

4.8 ± 0.4

4.9 ± 0.3

0.02

LVESV (mL)

59 ± 27

68 ± 26

0.03

LVEDV (mL)

98 ± 35

114 ± 35

0.01

LVEF (%)

39 ± 8

40 ± 8

0.1

LV Mass (gr)

198 ± 57

218 ± 54

0.005

LAD (cm)

3.6 ± 0.3

3.7 ± 0.2

0.03

sPAP (mmHg)

33 ± 12

34 ± 12

0.5

E/E’

11±5

8±4

0.05

**Table 3.** The Change of Echocardiographic Parameters at Baseline and First Month in the Total-Medical Group
	Baseline	First month	p value
Data expressed as mean ± SD, P < 0.05 was accepted as a statistically significant. LV:Left ventricular LVDD: Left ventricular diastolic diameter, LVSD: Left ventricular systolic diameter, LVEDV: Left ventricular enddiastolic volume, LVESV: Left ventricular endsystolic volume, LVEF: Left ventricular ejection fraction, LVM: Left ventricular mass, LAD: left atrial diameter, sPAP: systolic pulmonary artery pressure, E/E’: ratio of transmitral E velosity to myocardial E velosity
LVSD (cm)	3.8 ± 0.5	3.8 ± 0.4	0.5
LVDD (cm)	5.0 ± 0.5	5.0 ± 0.4	0.3
LVESV (mL/mm2)	75 ± 23	82 ± 25	0.1
LVEDV (mL/mm2)	113 ± 27	126 ± 29	0.05
LVEF (%)	35 ± 9	36 ± 9	0.2
LV Mass (gr)	214 ± 67	235 ± 73	0.04
LAD (cm)	3.7 ± 0.4	3.7 ± 0.4	0.9
sPAP (mmHg)	38 ± 11	36 ± 9	0.2
E/E’	10±4	8±3	0.02

Table 3. The Change of Echocardiographic Parameters at Baseline and First Month in the Total-Medical Group

Baseline

First month

p value

Data expressed as mean ± SD, P < 0.05 was accepted as a statistically significant. LV:Left ventricular LVDD: Left ventricular diastolic diameter, LVSD: Left ventricular systolic diameter, LVEDV: Left ventricular enddiastolic volume, LVESV: Left ventricular endsystolic volume, LVEF: Left ventricular ejection fraction, LVM: Left ventricular mass, LAD: left atrial diameter, sPAP: systolic pulmonary artery pressure, E/E’: ratio of transmitral E velosity to myocardial E velosity

LVSD (cm)

3.8 ± 0.5

3.8 ± 0.4

0.5

LVDD (cm)

5.0 ± 0.5

5.0 ± 0.4

0.3

LVESV (mL/mm2)

75 ± 23

82 ± 25

0.1

LVEDV (mL/mm2)

113 ± 27

126 ± 29

0.05

LVEF (%)

35 ± 9

36 ± 9

0.2

LV Mass (gr)

214 ± 67

235 ± 73

0.04

LAD (cm)

3.7 ± 0.4

0.9

sPAP (mmHg)

38 ± 11

36 ± 9

0.2

E/E’

10±4

8±3

0.02

**Table 4.** The Change of Echocardiographic Parameters at Baseline and First Month in the Subtotal-PCI Group
	Baseline	First month	p value
Data expressed as mean ± SD, P < 0.05 was accepted as a statistically significant. LV:Left ventricular LVDD: Left ventricular diastolic diameter, LVSD: Left ventricular systolic diameter, LVEDV: Left ventricular enddiastolic volume, LVESV: Left ventricular endsystolic volume, LVEF: Left ventricular ejection fraction, LVM: Left ventricular mass, LAD: left atrial diameter, sPAP: systolic pulmonary artery pressure, E/E’: ratio of transmitral E velosity to myocardial E velosity
LVSD (cm)	3.7 ± 0.5	3.8 ± 0.5	0.5
LVDD (cm)	5.0 ± 0.5	5.1 ± 0.5	0.2
LVESV (mL/mm2)	66 ± 30	68 ± 32	0.4
LVEDV (mL/mm2)	113 ± 40	115 ± 38	0.5
LVEF (%)	42 ± 9	42 ± 9	0.3
LV Mass (gr)	220 ± 59	231 ± 69	0.07
LAD (cm)	3.7 ± 0.5	3.7 ± 0.4	0.5
sPAP (mmHg)	32 ± 10	29 ± 10	0.02
E/E’	9 ± 4	8 ± 3	0.1

Table 4. The Change of Echocardiographic Parameters at Baseline and First Month in the Subtotal-PCI Group

Baseline

First month

p value

Data expressed as mean ± SD, P < 0.05 was accepted as a statistically significant. LV:Left ventricular LVDD: Left ventricular diastolic diameter, LVSD: Left ventricular systolic diameter, LVEDV: Left ventricular enddiastolic volume, LVESV: Left ventricular endsystolic volume, LVEF: Left ventricular ejection fraction, LVM: Left ventricular mass, LAD: left atrial diameter, sPAP: systolic pulmonary artery pressure, E/E’: ratio of transmitral E velosity to myocardial E velosity

LVSD (cm)

3.7 ± 0.5

3.8 ± 0.5

0.5

LVDD (cm)

5.0 ± 0.5

5.1 ± 0.5

0.2

LVESV (mL/mm2)

66 ± 30

68 ± 32

0.4

LVEDV (mL/mm2)

113 ± 40

115 ± 38

0.5

LVEF (%)

42 ± 9

0.3

LV Mass (gr)

220 ± 59

231 ± 69

0.07

LAD (cm)

3.7 ± 0.5

3.7 ± 0.4

0.5

sPAP (mmHg)

32 ± 10

29 ± 10

0.02

E/E’

9 ± 4

8 ± 3

0.1